ReviewPathogens & immunity2024

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin's Lymphoma.

Maria Florencia Giraudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.